The association between complement component 2/complement factor B polymorphisms and age-related macular...

Area of Science:

• Genetics
• Ophthalmology
• Immunology

Background:

• Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults.
• The complement system, particularly complement component 2 (C2) and complement factor B (CFB), plays a role in AMD pathogenesis.
• Genetic variations within C2 and CFB genes are potential risk or protective factors for AMD.

Purpose of the Study:

• To systematically review and meta-analyze the association between C2/CFB gene polymorphisms and AMD risk.
• To provide a robust estimate of the protective effects of specific C2/CFB alleles against AMD.

Main Methods:

• Systematic review and meta-analysis of 19 studies published between 2006 and 2011.
• Pooled data for four specific polymorphisms: rs9332739 and rs547154 (C2), and rs4151667 and rs641153 (CFB).
• Independent data extraction and risk of bias assessment by two reviewers; explored heterogeneity and publication bias.

Main Results:

• Minor alleles in C2 (rs9332739, rs547154) and CFB (rs4151667, rs641153) were associated with a reduced risk of AMD (ORs ranging from 0.41 to 0.55).
• These protective alleles contributed to an absolute risk reduction of 2.0%-6.0% for AMD in Caucasian populations.
• Pooled minor allele frequencies were generally low (4.7%-9.6%), with an exception in an Indian population for rs9332739.

Conclusions:

• Specific C2 and CFB gene polymorphisms demonstrate a significant protective association with age-related macular degeneration.
• This meta-analysis provides strong evidence supporting the role of the complement system, specifically C2 and CFB, in mitigating AMD risk.